Molecular and Cellular Mechanism in Rhinitis Allergic Patients Treated With GRAZAX®

Summary

The specific clinical trial is a part in which ALK- Abelló will directly work to explore human immunological mechanisms of SIT (observed after GRAZAX treatment).

Timeline

Start

2009-09

Primary completion

2014-12

Completion

2014-12

Publications

• Results Suarez-Fueyo A, Ramos T, Galan A, Jimeno L, Wurtzen PA, Marin A, de Frutos C, Blanco C, Carrera AC, Barber D, Varona R. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation. J Allergy Clin Immunol. 2014 Jan;133(1):130-8.e1-2. doi: 10.1016/j.jaci.2013.09.043. Epub 2013 Nov 28.

Drugs

Indications